I'm thrilled to sit down with Ivan Kairatov, a biopharma expert with extensive experience in research and development, particularly in the realm of innovative cancer treatments. With a deep understanding of technology and its application in the industry, Ivan is here to share insights on a
The fight against cancer is entering a bold new era, where the intricacies of tumor biology are reshaping the very foundation of clinical trials and therapeutic development, moving beyond outdated methods to address the real challenges of treatment resistance. For too long, cancer treatments have
Imagine a world where chronic diseases like cardiovascular disorders, metabolic conditions, and autoimmune issues are treated not by altering the very fabric of DNA, but by subtly tweaking how genes are expressed—a safer, more precise approach to healing that could transform countless lives.
Small cell lung cancer (SCLC) continues to pose a significant challenge in oncology, with its aggressive progression and limited treatment avenues leaving patients and clinicians grappling for solutions. Representing roughly 10-12% of all lung cancer diagnoses worldwide, SCLC is notorious for rapid
Cancer continues to be one of the most daunting challenges in modern healthcare, with millions of lives affected annually by its devastating impact, and traditional treatments like chemotherapy and radiation, while often effective, frequently bring debilitating side effects and inconsistent
England faces an unprecedented public health challenge as projections indicate a staggering 6.3 million new cancer diagnoses by 2040, effectively doubling the current rate and resulting in a new case every two minutes, driven by an aging population and lifestyle factors such as smoking and obesity.
